Your browser doesn't support javascript.
Human recombinant soluble ACE2 in severe COVID-19.
Zoufaly, Alexander; Poglitsch, Marko; Aberle, Judith H; Hoepler, Wolfgang; Seitz, Tamara; Traugott, Marianna; Grieb, Alexander; Pawelka, Erich; Laferl, Hermann; Wenisch, Christoph; Neuhold, Stephanie; Haider, Doris; Stiasny, Karin; Bergthaler, Andreas; Puchhammer-Stoeckl, Elisabeth; Mirazimi, Ali; Montserrat, Nuria; Zhang, Haibo; Slutsky, Arthur S; Penninger, Josef M.
  • Zoufaly A; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria. Electronic address: alexander.zoufaly@gesundheitsverbund.at.
  • Poglitsch M; Attoquant Diagnostics GmbH, Vienna, Austria.
  • Aberle JH; Center of Virology, Medical University Vienna, Vienna, Austria.
  • Hoepler W; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Seitz T; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Traugott M; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Grieb A; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Pawelka E; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Laferl H; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Wenisch C; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Neuhold S; Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Haider D; Department of Pharmacy, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
  • Stiasny K; Center of Virology, Medical University Vienna, Vienna, Austria.
  • Bergthaler A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Puchhammer-Stoeckl E; Center of Virology, Medical University Vienna, Vienna, Austria.
  • Mirazimi A; Department of Laboratory Medicine, Karolinska institute, Stockholm, Sweden.
  • Montserrat N; Catalan Institution for Research and Advanced Studies (ICREA), Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Technology (BIST) Barcelona, Spain.
  • Zhang H; Keenan Research Center, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON Canada.
  • Slutsky AS; Keenan Research Center, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON Canada.
  • Penninger JM; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Lancet Respir Med ; 8(11): 1154-1158, 2020 11.
Article in English | MEDLINE | ID: covidwho-793989
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Recombinant Proteins / Coronavirus Infections / Peptidyl-Dipeptidase A Type of study: Case report / Prognostic study Limits: Female / Humans / Middle aged Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Recombinant Proteins / Coronavirus Infections / Peptidyl-Dipeptidase A Type of study: Case report / Prognostic study Limits: Female / Humans / Middle aged Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article